Literature DB >> 32278832

Acute NelfA knockdown restricts compensatory gene expression and precipitates ventricular dysfunction during cardiac hypertrophy.

Saleena Alikunju1, Elena Severinova1, Zhi Yang1, Andreas Ivessa1, Danish Sayed2.   

Abstract

Coordinated functional balance of negative and positive transcription complexes maintain and accommodate gene expression in hearts during quiescent and hypertrophic conditions, respectively. Negative elongation factor (Nelf) complex has been implicated in RNA polymerase II (pol II) pausing, a widespread regulatory transcriptional phenomenon observed across the cardiac genome. Here, we examine the role of NelfA aka, Wolf-Hirschhorn syndrome candidate 2 (Whsc2), a critical component of the negative elongation complex in hearts undergoing pressure-overload induced hypertrophy. Alignment of high-resolution genome-wide occupancy data of NelfA, Pol II, TFIIB and H3k9ac from control and hypertrophied hearts reveal that NelfA associates with active gene promoters. High NelfA occupancy is seen at promoters of essential and cardiac-enriched genes, expressed under both quiescent and hypertrophic conditions. Conversely, de novo NelfA recruitment is observed at inducible gene promoters with pressure overload, accompanied by significant increase in expression of these genes with hypertrophy. Interestingly, change in promoter NelfA levels correlates with the transcript output in hypertrophied hearts compared to Sham, suggesting NelfA might be playing a critical role in the regulation of gene transcription during cardiac hypertrophy. In vivo knockdown of NelfA (siNelfA) in hearts subjected to pressure-overload results in early ventricular dilatation and dysfunction, associated with decrease in expression of inducible and cardiac-enriched genes in siNelfA hypertrophied compared to control hypertrophied hearts. In accordance, in vitro knockdown of NelfA in cardiomyocytes showed no change in promoter pol II, however significant decrease in in-gene and downstream pol II occupancy was observed. These data suggest an inhibited pol II progression in transcribing and inducible genes, which reflects as a decrease in transcript abundance of these genes. These results indicate that promoter NelfA occupancy is essential for pol II -dependent transcription. Therefore, we conclude that NelfA is required for active transcription and gene expression during cardiac hypertrophy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Functional genomics; Gene expression and regulation; Heart failure; Hypertrophy; Negative elongation factor complex; NelfA; RNA pol II pausing

Mesh:

Substances:

Year:  2020        PMID: 32278832      PMCID: PMC7275912          DOI: 10.1016/j.yjmcc.2020.04.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  35 in total

1.  Muscle and non-muscle cell RNA polymerase activity during the development of myocardial hypertrophy.

Authors:  A F Cutilletta; M Rudnik; R Zak
Journal:  J Mol Cell Cardiol       Date:  1978-08       Impact factor: 5.000

2.  Messenger RNA content and complexity in normal and overloaded rat heart.

Authors:  D de la Bastie; J M Moalic; J Bercovici; P Bouveret; K Schwartz; B Swynghedauw
Journal:  Eur J Clin Invest       Date:  1987-06       Impact factor: 4.686

3.  A highly purified RNA polymerase II elongation control system.

Authors:  D B Renner; Y Yamaguchi; T Wada; H Handa; D H Price
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

4.  The Wolf-Hirschhorn syndrome. I. Genetics.

Authors:  I W Lurie; G I Lazjuk; Y I Ussova; E B Presman; D B Gurevich
Journal:  Clin Genet       Date:  1980-06       Impact factor: 4.438

5.  Human negative elongation factor activates transcription and regulates alternative transcription initiation.

Authors:  Jianlong Sun; Rong Li
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

Review 6.  Progression through the RNA polymerase II CTD cycle.

Authors:  Stephen Buratowski
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

7.  NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly.

Authors:  Daniel A Gilchrist; Sergei Nechaev; Chanhyo Lee; Saikat Kumar B Ghosh; Jennifer B Collins; Leping Li; David S Gilmour; Karen Adelman
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

8.  TFIIH phosphorylation of the Pol II CTD stimulates mediator dissociation from the preinitiation complex and promoter escape.

Authors:  Koon Ho Wong; Yi Jin; Kevin Struhl
Journal:  Mol Cell       Date:  2014-04-17       Impact factor: 17.970

9.  Negative elongation factor controls energy homeostasis in cardiomyocytes.

Authors:  Haihui Pan; Kunhua Qin; Zhanyong Guo; Yonggang Ma; Craig April; Xiaoli Gao; Thomas G Andrews; Alex Bokov; Jianhua Zhang; Yidong Chen; Susan T Weintraub; Jian-Bing Fan; Degeng Wang; Yanfen Hu; Gregory J Aune; Merry L Lindsey; Rong Li
Journal:  Cell Rep       Date:  2014-03-20       Impact factor: 9.423

10.  Structure of paused transcription complex Pol II-DSIF-NELF.

Authors:  Seychelle M Vos; Lucas Farnung; Henning Urlaub; Patrick Cramer
Journal:  Nature       Date:  2018-08-22       Impact factor: 49.962

View more
  1 in total

1.  G3bp1 - microRNA-1 axis regulates cardiomyocyte hypertrophy.

Authors:  Saleena Alikunju; Nandita Niranjan; Maha Mohsin; Nazish Sayed; Danish Sayed
Journal:  Cell Signal       Date:  2022-01-10       Impact factor: 4.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.